Grupo De Investigación Plebio Universidad Nacional De Colombia Unal. Jdr, Fht, Oscar Lizarazo. Uaem Unal Colombia; Centro De Pensamiento, Medicamentos Unal And Others Opposition, Nirmatrelvir / Ritonavir (Paxlovid), (Pct/Ib2021/057281 Wo/2021/250648 )
No Annotations
Alert me when there are new annotations for this document
1 similar patent oppositions
-
Fundación Grupo Efecto Positivo opposition, Nirmatrelvir and Ritonavir [PAXLOVID], (AR123111A1)
Countries: Argentina Date: 2022